Literature DB >> 11772769

Adequacy of treatment for serious mental illness in the United States.

Philip S Wang1, Olga Demler, Ronald C Kessler.   

Abstract

OBJECTIVES: The purpose of this study was to assess the prevalence and correlates of treatment for serious mental illness.
METHODS: Data were derived from the National Comorbidity Survey, a cross-sectional, nationally representative household survey assessing the presence and correlates of mental disorders and treatments. Crude and adjusted likelihoods of receiving treatment for serious mental illness in the previous 12 months were calculated.
RESULTS: Forty percent of respondents with serious mental illness had received treatment in the previous year. Of those receiving treatment, 38.9% received care that could be considered at least minimally adequate, resulting in 15.3% of all respondents with serious mental illness receiving minimally adequate treatment. Predictors of not receiving minimally adequate treatment included being a young adult or an African American, residing in the South, being diagnosed as having a psychotic disorder, and being treated in the general medical sector.
CONCLUSIONS: Inadequate treatment of serious mental illness is an enormous public health problem. Public policies and cost-effective interventions are needed to improve both access to treatment and quality of treatment.

Entities:  

Mesh:

Year:  2002        PMID: 11772769      PMCID: PMC1447396          DOI: 10.2105/ajph.92.1.92

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  52 in total

1.  The obligation of mental health services to the least well off.

Authors:  H H Goldman
Journal:  Psychiatr Serv       Date:  1999-05       Impact factor: 3.084

2.  Principles for priority setting in mental health services and their implications for the least well off.

Authors:  R A Rosenheck
Journal:  Psychiatr Serv       Date:  1999-05       Impact factor: 3.084

3.  Differences between detected and undetected patients in primary care and depressed psychiatric patients.

Authors:  T L Schwenk; J C Coyne; S Fechner-Bates
Journal:  Gen Hosp Psychiatry       Date:  1996-11       Impact factor: 3.238

4.  The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.

Authors:  C A Melfi; A J Chawla; T W Croghan; M P Hanna; S Kennedy; K Sredl
Journal:  Arch Gen Psychiatry       Date:  1998-12

5.  Diagnosis and need for treatment are not the same.

Authors:  R L Spitzer
Journal:  Arch Gen Psychiatry       Date:  1998-02

6.  Community mental health and ethnic minority populations.

Authors:  F K Cheung; L R Snowden
Journal:  Community Ment Health J       Date:  1990-06

7.  Mental health services providers' distribution across countries in the United States.

Authors:  D J Knesper; J R Wheeler; D J Pagnucco
Journal:  Am Psychol       Date:  1984-12

8.  Why do schizophrenic patients refuse to take their drugs?

Authors:  T Van Putten
Journal:  Arch Gen Psychiatry       Date:  1974-07

9.  Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials.

Authors:  K Wahlbeck; M Cheine; A Essali; C Adams
Journal:  Am J Psychiatry       Date:  1999-07       Impact factor: 18.112

Review 10.  Competing demands in psychosocial care. A model for the identification and treatment of depressive disorders in primary care.

Authors:  M S Klinkman
Journal:  Gen Hosp Psychiatry       Date:  1997-03       Impact factor: 3.238

View more
  122 in total

1.  Social determinants of mental health treatment among Haitian, African American, and White youth in community health centers.

Authors:  Nicholas Carson; Ben Lê Cook; Margarita Alegria
Journal:  J Health Care Poor Underserved       Date:  2010-05

Review 2.  Bias in mental health assessment and intervention: theory and evidence.

Authors:  Lonnie R Snowden
Journal:  Am J Public Health       Date:  2003-02       Impact factor: 9.308

3.  Quality of follow-up after hospitalization for mental illness among patients from racial-ethnic minority groups.

Authors:  Nicholas J Carson; Andrew Vesper; Chih-Nan Chen; Benjamin Lê Cook
Journal:  Psychiatr Serv       Date:  2014-07       Impact factor: 3.084

4.  Probability and predictors of treatment-seeking for substance use disorders in the U.S.

Authors:  Carlos Blanco; Miren Iza; Jorge Mario Rodríguez-Fernández; Enrique Baca-García; Shuai Wang; Mark Olfson
Journal:  Drug Alcohol Depend       Date:  2015-02-09       Impact factor: 4.492

5.  Intersection of race-ethnicity and gender in depression care: screening, access, and minimally adequate treatment.

Authors:  Hyeouk Chris Hahm; Benjamin Lê Cook; Andrea Ault-Brutus; Margarita Alegría
Journal:  Psychiatr Serv       Date:  2014-12-01       Impact factor: 3.084

6.  An innovative model to coordinate healthcare and social services for people with serious mental illness: A mixed-methods case study of Maryland's Medicaid health home program.

Authors:  Emma E McGinty; Alene Kennedy-Hendricks; Sarah Linden; Seema Choksy; Elizabeth Stone; Gail L Daumit
Journal:  Gen Hosp Psychiatry       Date:  2017-12-16       Impact factor: 3.238

7.  Discontinuation of antidepressant medication among Latinos in the USA.

Authors:  Dominic Hodgkin; Joanna Volpe-Vartanian; Margarita Alegría
Journal:  J Behav Health Serv Res       Date:  2007-06-15       Impact factor: 1.505

8.  Activating older adults with serious mental illness for collaborative primary care visits.

Authors:  Stephen J Bartels; Kelly A Aschbrenner; Stephanie A Rolin; Delia Cimpean Hendrick; John A Naslund; Marjan J Faber
Journal:  Psychiatr Rehabil J       Date:  2013-11-11

Review 9.  The economic burden of depression and the cost-effectiveness of treatment.

Authors:  Philip S Wang; Gregory Simon; Ronald C Kessler
Journal:  Int J Methods Psychiatr Res       Date:  2003       Impact factor: 4.035

10.  Disparities in mental health service use of racial and ethnic minority elderly adults.

Authors:  Daniel E Jimenez; Ben Cook; Stephen J Bartels; Margarita Alegría
Journal:  J Am Geriatr Soc       Date:  2012-12-18       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.